# EPHEDRINE SULFATE
> **ANDA215825** · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2022-04-21
## Drug
- **FDA Application Number:** ANDA215825
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** EPHEDRINE SULFATE
- **Generic name:** EPHEDRINE SULFATE
- **Active ingredients:** EPHEDRINE SULFATE
- **Dosage form:** SOLUTION
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** XIROMED
- **Manufacturer:** Xiromed, LLC
- **First approval:** 2022-04-21
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215825)
---
*MORVS · CC0 1.0*